Patent ID: 8513285

Claim:
A method of treating depression, anxiety or pain disorder in a mammal in need of such treatment which comprises administering to said mammal an effective amount of a racemic or enantiomerically enriched 3- or 4-substituted piperidine compound represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof, wherein: A is naphthyl, which may be substituted with one or more identical or different substituents selected from the group consisting of hydrogen, halogen, straight- or branched-chain alkyl of from 1 to 4 carbon atoms, straight- or branched-chain alkoxy of from 1 to 3 carbon atoms, nitro, cyano, trifluoromethyl, trifluoromethoxy, methanesulfonyl, phenyloxy, phenyl and thienyl; B is an azole selected from the group consisting of triazole, benzotriazole, tetrazole, 5-methyl tetrazole and 5-phenyl tetrazole which are linked by nitrogen as represented by the following structural formulae (II); and one of X and Y is CH 2 and the other is N—R wherein R is hydrogen or a C 1-4 alkyl group.